{
  "id": 17091565,
  "title": "Chemo-Free First-Line Treatment Yields Huge PFS Gain in dMMR Endometrial Cancer",
  "url": "https://urgent.news/2026/10/29/chemo-free-first-line-treatment-yields-huge-pfs-gain-in-dmmr",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-29T15:59:30.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/esmo/123637"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Single-agent immunotherapy as first-line treatment led to a huge improvement in progression-free survival (PFS) in inoperable recurrent/advanced mismatch repair-deficient (dMMR) endometrial cancer, a large randomized trial showed...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}